Position in HLN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$9,059
New position
Shares Held
971
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#489
of 639 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Evelyn Partners Group Ltd holds $13,397,795 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #5 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
176,390 | $12,675,384 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
15,474 | $634,897 | |
| 3 | VTRS |
Viatris Inc
|
3,642 | $57,834 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
480 | $16,262 | |
| 5 | HLN |
Haleon plc
This page
|
971 | $9,059 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
272 | $4,359 |
All Filings in HLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,059 | 971 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||